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Increasing knowledge in the field of primate and human malaria has shown
the extent of the antigenic diversity that occurs in the asexual erythrocytic stages
of Plasmodium. Such plasticity of the parasite's antigenic makeup could explain
the slow development and incomplete nature of the protective immune response
against malaria . Naturally occurring (S antigen [ 1 ], 195 kD antigen ofPlasmodium
falciparum [2]) and induced (HRP/K+ antigen of P. falciparum [3, 4], 140 kD
antigen of P. knowlesi [5]) antigenic polymorphism has been described. Evidence
was at first acquired with an uncloned line of a primate malaria parasite, P.
knowlesi in an experimental host, the rhesus monkey, indicating that antigenic
variation was one of the mechanisms that contributed to the antigenic hetero-
geneity of the parasite (6). This was later confirmed with a cloned line of the
parasite (7). Evidence was also obtained in favor of the existence of antigenic
variation on the surface of P. falciparum-infected erythrocytes (8) in an experi-
mental host, the squirrel monkey; however, this study was performed with
uncloned parasites. In the present study, we have explored antigenic variation
in a natural host-parasite association, P. fragile in the toque monkey. Using a
cloned line of the parasite, we have demonstrated, that antigenic variation
occurred during the spontaneous evolution of infection, and that the different
variant antigenic types (VATS)' followed one another in a sequential order.
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Materials and Methods
Animals.
￿
The toque monkey Macaca sinica, the natural host of P. fragile in Sri Lanka
was used in this study. Wild-caught animals, both male and female, 3-5 kg, were
quarantined, screened for malaria, and those that had no previous exposure to malaria
were used for experiments.
Splenectomies were performed using a standard sterile technique, taking care in
identifying and removing all accessory spleens. Spleen-intact animals will be referred to
as S+, and splenectomized animals as S- animals.
Parasites.
￿
A cloned strain of P. fragile, kindly provided by Dr. J. H . Leech (Malaria
Division, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious
OThis work was supported by the United Nations Development Program/World Bank/World Health
rganization Special Programme for Research and Training in Tropical Diseases.
Abbreviations used in this paper:
￿
NMS, normal monkey serum; PE, parasitized erythrocyte; SIFT,
surface immunofluorescence test; VAT, variant antigenic types.
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Diseases, National Institutes of Health, Bethesda, MD) was used throughout this study.
Two lines of the parasite were derived, each by three consecutive serial passages, one in
S+ and the other in S- animals. Splenectomized animals were inoculated within 6-12 d
after splenectomy. The parasites were maintained either by cryopreservation (9) or by
blood passage, the S+ line in spleen-intact animals, and the S- line in splenectomized
animals. Animals were infected by intravenous inoculation of parasitized erythrocytes.
Infected blood was obtained by femoral puncture of anesthetized animals.
Short-term cultures of parasitized erythrocytes (PE) were maintained for one or two
cycles by the candlejar method (10) using normal toque monkey serum (NMS). Before
culture, leucocytes were removed by passing infected blood through a column of CF
cellulose powder (Whatman Ltd., Kent, United Kingdom) (11).
Hyperimmune Sera.
￿
Three S+ animals were immunized as follows: Animals were in-
fected with parasites from the S+ line, and once the parasitemia reached 1-5%, the
infection was cured with chloroquine treatment. The animals were challenged by three
intravenous inoculations of 106-10' autologous live parasites at 2-wk intervals. Hyperim-
mune sera were collected 7-10 d after the last challenge. Hyperimmune sera were
obtained from three S- animals using the same immunization schedule but using parasites
of the S- line.
Convalescent Sera.
￿
Convalescent sera were collected from seven S* animals during the
course of parasitemia of untreated infections, after the primary parasitemia peak and after
each recrudescence (Fig. 1). All sera were heat inactivated (30 min at 56°C). The IgG
fraction was separated from sera using protein A-Sepharose CL-4B (Sigma Chemical Co.,
St. Louis, MO) (12).
Surface Immunofuorescence Test (SIFT).
￿
A modification of the technique for surface
immunofluorescence (SIF) using fresh unfixed schizont-infected erythrocytes (13) was
used as follows: 100,l of each dilution of whole serum or the IgG fraction (6-12 mg/ml)
was incubated with 5,l ofpacked erythrocytes for 30 min, and centrifuged (MSE Scientific
Instruments, Sussex, United Kingdom) for 5 min at 500 g. The pellet was washed twice
in 100 A1 of medium and incubated with 100 kl ofa 1 :20 dilution of fluorescein-conjugated
IgG fraction of rabbit anti-monkey IgG (Cappel Laboratories, Cochranville, PA) for 30
min. All incubations were performed at room temperature (27 ° C). Culture medium
RPMI 1640 containing 10% FCS was used for all dilutions and washing procedures. The
cells were centrifuged as before and the pellet was washed twice in 100 Al, and resuspended
in 40 j1 of medium. A drop of this suspension was examined under x 100 magnification
of a Leitz Diaplan Microscope. Infected erythrocytes were recognized under phase-
contrast optics by the presence of malaria pigment. The indirect immunofluorescence test
(IFT) using acetone-fixed thin films of schizont-infected erythrocytes as antigen (14) was
also performed using the same sera and conjugate as above.
Assay for Intraerythrocytic Growth Inhibition.
￿
Infected erythrocytes containing ring
stages (at ^-5 h of erythrocytic development) of the parasite were obtained from S' and
S- animals that had synchronous infections, and cultured in vitro at a 10% hematocrit in
culture medium containing 10% NMS. At 18-20 h of erythrocytic development the
culture medium was replaced with one containing either immune serum at 5 III/ml or the
IgG fraction of immune serum at 0.3-0.5 mg/ml, and the hematocrit was decreased to
2-3% . Thin blood films were made in duplicate from each culture plate 24 h later when
parasites in normal culture medium had reached the schizont stage of development. The
total parasitemia and the percentage of schizonts in each culture plate were assessed by
microscopic examination of Giemsa-stained thin blood films.
Results
Natural Infections of P. fragile in Macaca sinica.
￿
P. fragile causes a nonlethal
infection in its natural host the toque monkey M. sinica . Untreated infections
consisted of a primary parasitemia peak (1 .0 ± 0.13%) and a series of smaller
recrudescences in which the parasitemia did not exceed 0.3% . Periods of sub-
patency (parasitemia <0 .004%) intervened between these parasitemia peaks (see
Fig. 1, first graph) .r
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FIGURE 1 .
￿
Sequential blood passage (1) of the S* line of P. fragile in S* animals. The
parasitemia was monitoreddailyin each animal, andsera (C 11-C 52)were collectedat various
times (T)during the course of untreated infections. V1, V2, V3, and V4 indicate the variant
antigenictype ofeach parasite population.
Surface Antigens on Infected Erythrocytes. Surface immunofluorescence of
erythrocytes infected with mature stages (late trophozoites and schizonts) of the
S+ line of the parasite was obtained with hyperimmune sera from S+ animals.
Distinct, fine fluorescent dots were seen throughout the erythrocyte membrane;
these dots were not confined to the area overlying the parasite (Fig. 2). >80%
of the trophozoite- and schizont- infected erythrocytes (recognizable by the1272
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FIGURE 2 . Surface immunofluorescence of PE of the S' line of the parasite . Infected
erythrocytes containing late trophozoites and schizonts were incubated with S' hyperimmune
serum followed by fluorescein-conjugated rabbit anti-monkey IgG . Apigment-containing late
trophozoite/schizont-infected erythrocyte in an unfixed erythrocyte suspension examined
under normal light (A) and the same field (X 1,250) under ultraviolet light (B), where the
infected erythrocyte shows surface immunofluorescence.HANDUNNETTI ET AL.
￿
1273
TABLE I
Surface Immunofuorescence Titers ofDistinct Parasite Populations
in Three S+ Animals with Convalescent Sera
* +, Positive at a titer of 1:5; -, negative at a titer of 1:5 .
visible pigment) gave a positive SIF, up to a titer of 1 :125 of S+ hyperimmune
serum.
Differences in Antigenicity in Parasites Obtained from Primary and Secondary
Parasitemia Peaks. The antigenic type of parasite populations of the primary
parasitemia peak and the first recrudescence were investigated using the tech-
nique of surface immunofluorescence of PE with immune sera specific to each
distinct parasite population. Parasites from the first recrudescence were studied
by passaging them into a naive nonimmune animal and thus obtaining immune
serum specific to the antigenic type of the recrudescent parasite population.
PE from the primary parasitemia peak of T72 were passaged into T76, and
from the first recrudescence of T76 into T85 (Fig. 1). The SIF results of live
unfixed PE from the primary parasitemia peak of T72, T76, and T85 with
convalescent sera obtained after the primary peak of these animals C 11, C 19,
and C 24 are shown in Table I. Convalescent sera C 11 and C 19 of animals T72
and T76, respectively, reacted positively with PE of primary parasitemia peaks
of both animals, but neither sera reacted with PE of the primary peak of T85,
indicating that the antigenic types of primary peaks of T72 and T76 were
identical. This demonstrated that when PE were passaged into a naive nonim-
mune animal they retained their antigenic type during the primary parasitemia
peak in the latter host.
Further, convalescent serum C 24 of animal T85, which reacted positively
with PE of the primary parasitemia peak of T85, did not react with PE of the
primary peak of T72 (Table 1). Because parasites of the primary peak of T85
were those passaged from the first recrudescence of T76, these results demon-
strate that surface antigens of PE of the first recrudescence (of T76) were
different from those of PE of the primary peak. Thus, this cloned parasite
undergoes antigenic variation during the course of an untreated natural infec-
tion.
Sequential Appearance of Variant Parasite Antigens.
￿
The appearance of VATS
during an untreated infection was studied in two sets of experiments. In one,
parasites were passaged from the primary parasitemia peak of T72 into T76,
from the first recrudescence of T76 into T85 as described before, and from the
first recrudescence of T85 into T100 (Fig. 1). Similarly another parallel set of
experiments were initiated by passaging parasites from the primary peak of T76
into T80 (Fig. 1). The parasites from the first recrudescence of T80 waspassaged
into T90 and from the first recrudescence of T90 into T102. The SIF results,of
live unfixed PE from the primary parasitemia peak of each animal with conva-
Serum Parasites from primary
peak of animal:
parasitemia
Animal Code T72 T76 T85
T72 C 11 +* + -
T76 C 19 + + -
T85 C 24 - ND +1274 ANTIGENIC VARIATION IN PLASMODIUM FRAGILE
TABLE II
Surface Immunofluorescence Titers ofLive Unfixed Schixont-infected Erythrocytes
Obtained from the Primary Parasitemia Peak ofSix S+ Animals with Antisera of
Seven S' Animals Collected at Various Times during the Course ofInfection
All sera, C 11-C 52 (see Fig. 1) were tested at four dilutions 1:5, 1:25, 1:125, and
1:250 .
* 1Rparasites obtained from the first recrudescence of T102.
$0, Negative at a titer of I:5.
lescent sera collected after the primary peak and each recrudescence are shown
in Table II.
Convalescent sera C 11, C 19, and C 31 of animals T72, T76, and T80,
respectively, reacted specifically in SIF with PE from the primary parasitemia
peaks of T72 and T80, but not with that of any other animal presented in Fig.
2 (Table II) indicating that the antigenic types of the primary peaks of T72,
T76, and T80 were identical, and that they differed from other antigenic types.
This antigenic type was designated as VAT V1, and convalescent sera were
defined as V 1 variant-specific sera.
Convalescent sera C 24 and C 46, of animals T85 and T90, respectively,
reacted with PE of the primary peaks of both animals, but not with PE from the
primary peaks of other animals. Thus the antigenic types of the primary peaks
of T85 and T90, which were parasites passaged from the first recrudescence of
T76 and T80, respectively, were identical, and differed from the VAT V 1 . This
new VAT of the primary peaks of T85 and T90 was designated VAT V2.
Serum Surface Immunofluorescence titers (reciprocals) for antigens:
Animal Code T72 T80 T85 T90 T100 T102 T102*
T72 C 11 5 25 0t 0 0 0 ND
C 17 25 125 25 5 0 0 ND
C 20 125 250 125 25 25 25 ND
T76 C 19 5 5 0 0 0 0 0
C 22 25 125 5 5 5 0 0
C 27 125 125 25 25 5 25 0
C 30 ND ND ND ND ND ND 5
T80 C 31 5 5 0 0 0 0 0
C 35 25 125 5 5 0 0 0
C 39 125 125 25 25 25 25 5
T85 C 24 0 0 5 5 0 0 0
C 32 0 0 25 5 5 5 0
C 37 0 0 25 25 5 25 5
T90 C46 0 0 5 ND 0 ND 0
C 47 0 0 25 ND 5 ND 5
C 48 0 0 125 ND 125 ND 5
T100 C 42 0 0 0 0 5 5 0
C 43 0 0 0 0 25 25 5
T102 C 49 0 0 0 ND 5 ND 0
C 51 0 0 0 ND 25 ND 5
C 52 0 0 0 ND 125 ND 25HANDUNNETTI ET AL.
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In animals T100 and T102, their convalescent sera (C 42 and C 49, respec-
tively) reacted with PE of the primary peaks ofboth animals, but not with VAT
VI or V2. Thus the PE of the primary peak of T100 and T102, which were
parasites passaged from the first recrudescence of T85 and T90, respectively,
had the same VAT, which was different from VAT V1 and V2 and was
designated VAT V3.
The PE of the first recrudescence ofanimal T102 consisted ofa distinct VAT
that did not react positively with VAT V1-, V2-, or V3-specific sera, but
reacted positively with its own convalescent serum, C 51. This VAT was desig-
nated VAT V4.
In these two sets of experiments the same sequential order ofappearance of
VATS were detected, VAT V1 followed by V2, followed by V3, followed by V4.
These results demonstrate that, in natural untreated infections, parasites of the
primary parasitemia peak and of each recrudescence contain different VATS,
and that they appear in a definite sequential order. This order of appearance is
maintained when the sequence is interrupted by passaging a VAT in the middle
ofthe sequence.
Convalescent sera obtained from these animals at various times during the
course of parasitemia and in relation to the appearance of recrudescences were
tested by SIF with parasites of known VATS V1, V2, and V3 (Table II). The
series of convalescent sera obtained from each animal reacted with the VATS
corresponding to the order ofappearance of variants, e.g., in T76, in which the
primary peak was shown to be VAT VI, C 19, the first convalescent serum
reacted only with PE ofVAT V1. The second convalescent serum, C 22, which
was obtained after the appearance ofthe first recrudescence, reacted with VAT
VI and also with VAT V2. Alater convalescent serum C 27, which was obtained
after the appearance of the second recrudescence, reacted with VAT V1, V2,
and also with V3, corroborating the evidence that during the course of parasit-
emia in the host, parasites undergo antigenic variation in a sequential order of
VAT V3 following V2, and V2 following VI.
Spleen Dependency of Variant Antigens.
￿
Schizont-infected erythrocytes of S+
and S- lines of the parasite were tested by surface immunofluorescence with
hyperimmune sera obtained from three S' and S- animals. Infected erythrocytes
of the S+ line gave a positive surface immunofluorescence with hyperimmune
sera from all three S+ immune animals and the IgG fraction of these sera, but
did not react with hyperimmune sera or the IgG fraction of hyperimmune sera
from any ofthe three S- animals (Table III). Infected erythrocytes ofthe S- line
did not react with hyperimmune sera from either S' or S- immune animals.
IFT using acetone-fixed thin films ofPE as antigen, which detect both surface
as well as internal antigens, gave similar titers of 1 :2,560 and 1:5,120 with
hyperimmune sera from S' and S- animals, respectively, indicating that the
antibody response to immunizing infection was quantitatively comparable in both
S+ and S- animals. These immunofluorescence data indicate that surface anti-
gen(s) can only be detected in the S' line ofthe parasite.
The influence of the spleen on the expression ofsurface antigens was further
explored by transferring parasites of the S- line into S+ animals, and of the S+
line into S- animals. A large inoculum (2-5 x 109) of ring-infected erythrocytes
ofthe S- line were inoculated intravenously into each of four S+ animals so that1276
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TABLE III
Surface Immunofuorescence Titers of PE of the S+ and S- Lines of
theParasite with S+ and S- Hyperimmune Sera
Sera were used at four dilutions: 1:5, 1 :25, 1:125,and 1:250.
* 0, Negative at a titer of 1:5.
the parasitemia became patent in the recipient S' animals immediately after
inoculation. 48 h later, ring stage parasites from the next developmental cycle
were obtained, cultured in vitro up to the schizont stage and the SIFT was
performed with S+ hyperimmune sera. Surface antigens were detected on >80%
of schizont-infected erythrocytes, indicating that the switch in expression of
surfaceantigens had occurred within two erythrocytic cycles when nonexpressing
parasites of the S- line were transferred to an S+ animal .
Similarly, four splenectomized animals were each inoculated with 2.5 X 108
i.v. ring-infected erythrocytes ofthe S+ line. Ring-infected erythrocytes obtained
from each developmental cycle in the recipient S- animals were cultured in vitro
up to the schizont stage and the SIFT was performed with S' hyperimmune
serum. In three of the recipient S` animals, surface antigens were still detectable
in 80-95% of schizont-infected erythrocytes during the second and third devel-
opmental cycles. In the fourth animal, the number ofschizont-infected erythro-
cytes positive for surface immunofluorescence had dropped to 50% by the third
developmental cycle. Gradually both the percentage of PE positive for surface
immunofluorescence and the intensity of the fluorescence decreased in all
animals. By the seventh developmental cycle in the S- host only 20% of PE, and
by the 24th developmental cycle <10% of PE were positive for SIT.
Antigenic Variation in the S- Line of the Parasite.
￿
The course of infection of
the S- line of the parasite in the splenectomized host consisted ofa high primary
parasitemia peak (parasitemia 21.6 ± 9.1%; mean ± SE) followed by successive
peaks of low parasitemia; here, unlike in the case of S- animals, the peaks were
not always separated by periods of subpatency but by very low patent parasite-
mias. Surface antigens were not expressed on infected erythrocytes ofthe S- line
of the parasite, but as mentioned earlier, when transferred into a naive nonim-
mune S' animal, surface antigens were expressed in the recipient S+ animal by
the second erythrocytic cycle (parasitemia in thefirstcycle wastoo low to perform
the SIFT). This phenomenon of switching from nonexpression to expression of
surface antigens within two erythrocytic cycles when transferred from an S- to
an S+ animal was used to explore antigenic variation in the S- animal, as follows.
Two sets of experiments were initiated by inoculating two splenectomized
animals, T148 and T156, with parasites of the S- line (Fig. 3A) from a single
Immunized
animal Serum
Antigen
PE ofthe
S' line
PE of the
S-line
T43/S' 124 1:125 0*
T47/S' 125 1:125 0
T63/S' 151 1:125 0
T34/S- 111 0 0
T60/S' 140 0 0
T64/S- 141 0 0< 0.,_
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￿
Passageof PE from the primary parasitemia peak and recrudescences of infected
S- animals to naive S' animals. Two S- animals, T148 and T156 (A), were inoculated
intravenously with cryopreserved parasites of the S- line. PE from the primary peak of these
two S- animals was passaged (1) into two S' animals, T140 and T163 (B). PE from the second
recrudescence of the two S- animals were passaged each through two S- animals, T149 and
T158, respectively (C) into two S' animals, T142 and T161, respectively (D). The VAT
expressed in the S' animalsare indicated in the squares (V.).
cryopreserved source. Parasites from the primary parasitemia peak of the two S-
animals were passaged into two naive nonimmune S+ animals (Fig. 3B), T140
and T163, respectively, using a large inoculum so that the infection became
patent immediately in the recipient animals. The SIFT was performed on PE
from the primary parasitemia peak of the recipient S+ animals, using variant-
specific sera. PE from both animals only reacted with VAT VI-specific serum
and not with VAT V2- or V3-specific sera. Thus, parasites from both animals
had the potential, when transferred into an S+ animal, to switch to an expression
characteristic of VAT V1 .
We then transferred PE from the second recrudescence of T148 and T156
each through another S- host (T149 and T158, respectively) (Fig. 3C) into an
S+ host, T142 and T161, respectively (Fig. 3D). The intermediate S- hosts T149
and T158 were used to amplify the number of parasites of the recrudescences,
so that a large inoculum could be passaged into the S+ hosts, enabling the
parasitemia to become patent immediately. The SIFT was performed on PE
from the primary peak of the two recipient S+ animals T142 and T161 (Fig. 3D)
using variant-specific sera. PE from T142 and T161 reacted only with VAT
V3-specific serum and not with antisera of any other specificity, indicating that
PE from the second recrudescence of the S- animal T148 and T156 had varied
in its potential VAT from V1, through the second recrudescence, to V3 . Thus
mechanisms leading to antigenic variation do occur in the S- animal although1278
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TABLE IV
Effect ofImmune Serum on Intraerythrocytic Development of
Parasites ofthe S+ and S- Lines
Serum
Percentage of schizonts*
PE of the S' line
￿
PE of the S- line
M 20
￿
66.00± 6.33
￿
67.00 ± 3.79
125
￿
25.00± 10.00
￿
63.33 ± 3.29
140
￿
62.27 ± 2.68
￿
64.33 f 4.38
Early trophozoites of S' and S- lines were cultured with S' (1 25) and
S- (140) hyperimmunesera at 5,ul/ml and with normal monkey serum
(M 20). The percentage of schizonts was assessed after 24 h.
* Mean ± SE of threeexperiments.
the variant antigens do not appear either to be expressed on the surface of PE
(S' or S- hyperimmune sera do not react with PE of the S- line) or occur
internally (variant-specific antibodies cannot be detected in S- hyperimmune
sera).
Effect of Hyperimmune Serum on the Intraerythrocytic Development of S+ and S-
Lines ofthe Parasite. The effect of hyperimmune sera of S+ and S- animals on
the intraerythrocytic development of S' and S- lines of the parasite was assessed
in in vitro cultures to investigate the possible significance in protective immunity
of these spleen-dependent surface antigen(s). The results of these experiments,
summarized in Table IV, demonstrate that S* hyperimmune serum had an
inhibitory effect on the intracellular development of the S+ line of the parasite,
arresting development at the late trophozoite stage (Fig. 4), resulting in a 62%
reduction in the number of schizonts, as compared with development in normal
monkey serum. This S+ hyperimmune serum however had no effect on the
intraerythrocytic development of parasites of the S- line. Further, S- hyperim-
mune serum had no effect on the development of parasites of either the S+ or
S- line.
Effect of Variant-specific Sera on the Intraerythrocytic Development of VATS of
Parasites of the S+ Line. The effect of variant-specific sera on the intraerythro-
cytic development of two VATS, V1 and V3 of the S' line of the parasite, is
shown in Table V. Developmentof parasitesof VAT V1 wasspecifically inhibited
by V1 variant-specific serum C 72, but not by V3 variant-specific serum C 43.
Also, the development of parasites of VAT V3 was specifically inhibited by V3
variant-specific serum, but not affected by Vl variant-specific serum. The IgG
fraction separated from the variant-specific sera had the same specific growth-
inhibitory effects as the respective sera.
The S' hyperimmune sera 1 51 and I 25, which reacted by SIT with both
VATS V1 and V3 and the IgG purified from these sera inhibited the intraeryth-
rocytic development of both VAT V1 and V3 .
Discussion
The natural infection of the toque monkey by P. fragile includes at first the
appearance of a major peak of parasitemia followed by a chronic evolution of
the infection in the form of several successive smaller parasitemia peaks. Immu-
nofluorescence using unfixed erythrocytes in suspension has shown that antigensHANDUNNETTI ET AL .
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FIGURE 4.
￿
Inhibition of intracellular growth o£ parasites of the S' line by immune serum .
PE containing early trophozoite stages (18-20 h of growth ; 1-2% parasitemia) of S' line were
cultured in S' hyperimmune serum 125 and S- hyperimmune serum 140 at 5 u1/ml. The
percentage parasitemia and percentage of schizonts were assessed after 24 h by microscopic
examination of Giemsa-stained thin blood films . Parasites developed into schizont stage in
cultures containing S- hyperimmune serum (A) and growth was arrested at late trophozoite
stage in cultures containing S' hyperimmune serum (B) . X 2,500 .
are recognized by immune serum on the surface of the erythrocytes infected
with more mature stages of the parasite . These antigens undergo variation, each
successive peak of parasitemia being characterizedby a different variant antigenic1280
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TABLE V
Effect of Variant-specific Sera on Intracellular Development of Two VATs
of the S+ Line of the Parasite
Percent inhibition* ofparasite development
VAT
￿
Exp .
￿
C 72
￿
C43
￿
15l
￿
1 40
Sera were used at 5 p,1/ml with NMS M 20 ; C 72, VI-specific ; C 43, V3-specific ; 1 51, S` hyperimmune
serum ; 140, S-hyperimmune serum .
* Percent inhibition = 100 X (percent schizonts in NMS or IgG) - (percent schizonts in test serum or
IgG)/(percent of schizonts in NMS or IgG),
Mean ±SE,n=6 .
type (VAT). The appearance of the successive VATS occurs in a sequential
manner, following the same order in different sets of animals . This constitutes
the first example ofa sequential expression of antigens in a malaria parasite ; it
indicates that in P.fragileantigenic variation is not the result ofrandom mutations
selected by antibody . In cloned trypanosomes, variantsurfaceantigens are known
to appear in a sequential manner during the course of an infection (15-17).
However, in contrast with the situation in trypanosomes where the mechanisms
of antigenic variation have been extensively studied (reviewed in 18), the mech-
anisms of antigenic variation in Plasmodium remain largely unknown .
The presence of the spleen has been shown to play a major role in the
expression of malarial antigens on the surface of infected erythrocytes . In the
case of P. falciparum in the squirrel monkey, a given cloned parasite expresses
different antigens on the surface of the erythrocyte in a spleen-intact and in a
splenectomized animal (8) . During the infection of the rhesus monkey by P.
knowlesi, the expression of the variant antigens on the surface of the schizont-
infected erythrocyte (schizont-infected cell agglutination [SICA) antigens) is
dependent on the presence of the spleen ; parasites from a splenectomized host
no longer express detectable SICA antigen on the surface of schizont-infected
erythrocytes (7) . This is comparable to what we have shown to occur in the
infection of the toque monkey by P . fragile, where antigens can no longer be
detected on the surface of erythrocytes in splenectomized animals . The obser-
vation that antibody recognizing the surface of infected erythrocytes from intact
animals are not found in hyperimmune sera from three splenectomized animals
indicates that VAT antigens are not only not expressed on the surface of the
erythrocyte but are either nonimmunogenic or absent from any other part of
the parasitized erythrocyte in the splenectomized animal . Thus the parasite exists
as two distinct phenotypes, S+ and S-, in relation to the expression of surface
antigens . The fact that they can switch from nonexpression to expression of
surface antigens within two erythrocytic cycles when transferred from an S- to
an S+ host environment favors the idea that the spleen modulates the expression
of these antigens rather than that the two phenotypes are the outcome of the
selection of mutant populations .
The absence of expression in the S- line of the parasite contrasts with the
Serum IgG Serum IgG Serum IgG Serum IgG
V I 1 39.98t3.48$ 37.10t4.89 -16.04t 6.46 -1.39 :t 2.69 49.69t3.46 44.16t4.16 9.91 t3.17 3.39 t3.16
11 34 .17 t2.73 24 .46 t 1 .16 -5.96± 2.75 -3.36 ± 1.64 40 .44 t2.54 50 .01 t4.24 -6.84t 3.41 -4 .31 t2.63
V3 111 6.41 t2.47 4.76 ±4.27 55.75t4.67 62.15t 1.72 49.37 t 1.44 59.18t 1.36 6.23t 1.15 8.37t2.81
IV ND ND 49.17t 7.91 ND 35 .67 t5.57 ND -3.33 t3.16 NDHANDUNNETTI ET AL.
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observation that events leading to changes in the VAT can occur in the splenec-
tomized animals. When a splenectomized animal is inoculated with S- parasites
of potential VAT V1 (these were parasites of the nonexpressing S- line, which
when transferred to an S+ animal express VAT VI), a chronic infection occurs,
made of successive peaks of low-grade parasitemia as in a spleen-intact animal
except that antigens are not expressed on the surface of the infected erythrocyte.
When parasites are isolated from the third peak ofparasitemia ofthe splenecto-
mized animal and inoculated into a spleen-intact animal, antigensare reexpressed
on the surface of the infected erythrocytes isolated from the first peak of
parasitemia (within two parasite cycles), and these antigens are shown to be of
VAT V3 type. This shows that, although the presence of the spleen is necessary
for the expression of the variant antigen(s) on the surface of the infected
erythrocyte, the process(es) leading to variation takes place in the absence ofthe
spleen.
Intraerythrocytic development ofP. fragile can be inhibited by antibody and
appears to be associated with the presence of antigens on the erythrocyte
membrane. Morphological evidence of growth inhibition is clear-cut, from total
arrest of growth to abnormal pycnotic forms resembling crisis forms. Inhibitory
effects of antibody on growth are not due to nonspecific toxicity, and indeed
appear to be associated with the presence ofantigens on the erythrocyte mem-
brane in as much as antibody has no effect on the growth of parasites from
splenectomized animals, which do not express antigen(s) on the surface of the
infected erythrocyte, and inhibitory effects of antibody were variant specific.
This suggests that it is the binding of antibody to variant antigens present on the
surface of the infected erythrocytes that is responsible at least in part for
inhibition of parasite development. Though several non-antibody-mediated
mechanisms (19, 20) are known to inhibit intraerythrocytic growth of Plasmodial
species, an antibody-mediated mechanism leading to arrest of intraerythrocytic
growth (as for example by the interaction of antibody with antigens on the
surface infected erythrocytes), has not been previously described.
Despite a striking immune-evasive parasite mechanism ofantigenic variation,
which we have demonstrated here, there is also evidence for host protection in
P. fragile, in that antibodies in hyperimmune serum from animals repeatedly
exposed to infection can react with the different VATS and block parasite
development of all VATs tested; and in natural infections, parasitemias are
eventually controlled and maintained at subpatent levels . It is possible that, after
repeated exposure to parasites, certain antigens on the infected erythrocyte
membrane can elicit an immune response capable of transcending antigenic
variation, or that there is a limited repertoire of VATS in P. fragile, to all of
which the host eventually acquires immunity.
Summary
The course of infection of Plasmodium fragile in its natural host, the toque
monkey Macaca sinica, consists of a primary peak of parasitemia followed by
several distinct, successive peaks of lower parasitemia. In the S+ host, the late
intraerythrocytic asexual developmental stages of P. fragile induce the expression
of antigens on the surface of infected erythrocytes, which could be detected
using the technique of surface immunofluorescence.1282
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Immunofluorescence using unfixed erythrocytes in suspension has shown that
antigens are recognized by immune serum on the surface of the erythrocytes
infected with more mature stages of the parasite. These antigens undergo
variation, each successive peak of parasitemia being characterized by a different
variant antigenic type (VAT). The appearance of the successive VATS occurs in
a sequential manner, following the same order in different sets of animals. This
constitutes the first example of a sequential expression of antigens in a malaria
parasite; it indicates that, in P. fragile, antigenic variation is not the result of
random mutations selected by antibody.
Parasite-induced antigens on the surface of infected erythrocytes could not be
detected in the S- host. However, when nonexpressing parasites from the S-
host were transferred by blood passage into a naive S' animal, they began to
express antigens on the surface of infected erythrocytes within two erythrocytic
cycles. We have demonstrated that the ability of S- parasites to switch to a
particular VAT when passaged into a S'' animal changes during the course of an
infection in the S- animal, indicating that, although surface antigens are not
expressed, the processes leading to antigenic variation occurs even in the S- host.
Antibodies directed against these surface antigens inhibit the growth of intra-
erythrocytic parasites. Thegrowth inhibition effectsof antibodies are also variant
specific, indicating that these variant surface antigens are functionally important
for parasite survival .
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